story of the week
Risk of Amputations Associated With SGLT2 Inhibitors Compared With DPP-4 Inhibitors
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Risk of Amputations Associated With SGLT2 Inhibitors Compared to DPP-4 Inhibitors: A Propensity-Matched Cohort Study
Diabetes Obes Metab 2018 Jul 03;[EPub Ahead of Print], S Adimadhyam, TA Lee, GS Calip, DE Smith Marsh, BT Layden, GT SchumockFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.